rethinkPeptides Search
Menu
Research citation

Outcome analysis in patients with metastatic gastroenteropancreatic neuroendocrine tumors receiving peptide receptor radionuclide therapy with Lu-177-DOTATATE.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Outcome analysis in patients with metastatic gastroenteropancreatic neuroendocrine tumors receiving peptide receptor radionuclide therapy with Lu-177-DOTATATE.

Journal of gastrointestinal oncology, 14(3), 1204-1217

Citation

Prétot, Dominique; Engel-Bicik, Ivette; Kenkel, David; Kaufmann, Philipp A; Treyer, Valerie; Siebenhüner, Alexander R. (2023). Outcome analysis in patients with metastatic gastroenteropancreatic neuroendocrine tumors receiving peptide receptor radionuclide therapy with Lu-177-DOTATATE.. Journal of gastrointestinal oncology, 14(3), 1204-1217. https://doi.org/10.21037/jgo-22-874